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Abstract
Background: The use of a prefabricated spacer in two-stage revision arthroplasty remains one of the few surgery
strategies for infected-joint arthroplasty treatment, despite the many unidentified microorganisms in the infected
joint replacements reported in some recent studies. The aim of this prospective survey was to investigate if the
sonication followed by polymerase chain reaction (PCR) can improve bacterial identification on the surfaces of
prefabricated spacers and if the systemic laboratory mediators of infection and positive microbiological results can
take a role of predictive factors of infection and clinical failures in 2-years follow-up.
Methods: Thirteen patients with prosthetic joint infection were investigated. Bacterial culture and deoxyribonucleic
acid (DNA) sequencing were used to detect bacteria on the surface of prefabricated spacers removed during the
second stage of revision arthroplasty. The results of pre- and intraoperative culture and DNA sequencing were
compared. Minimum follow-up was 2 years.
Results: The result of tissue cultures in second-stage revision arthroplasties revealed positive results in 15 % of patients
with Coagulase-negative Staphylococci (CNS) growth. Bacterial DNA was found in over 90 % of patients with negative
synovial fluid culture. Positive PCR results revealed potential pathogenic bacteria and species of human and
environmental microflora with low virulence. Clinical failures at final follow-up were recorded in 2 (16.6 %) patients.
Conclusion: The lack of clinical signs of infection, negative culture of preoperative joint aspirate, and intraoperative
specimens do not exclude the presence of bacteria on the surfaces of spacers. The positive results of sonication and
molecular tests should be interpreted as real pathogenicity factors in the light of the clinical and laboratory data,
especially for patients with immunodeficiency. We confirmed our previous results that sonication followed by PCR and
sequencing improved bacterial identification.
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Background
One of the most severe complications after joint replace-
ment is prosthetic joint infection (PJI). The risk of PJIs
occurs in 3.2–7 % of patients after revision arthroplasties
[1]. Currently, the two-stage exchange arthroplasty is the
preferred method of treating chronic PJI [2–6]. The use
of pre-formed spacers, which are implantable devices
indicated to temporarily replace a prosthesis in a septic
revision procedure, allow local antibiotic administration
and maintains patient mobility between stages. The usage
of prefabricated spacers limited the risk of spacer fracture
and facilitate procedure of second-stage arthroplasty [6].
A recent study revealed 73 % successful two-stage revision
arthroplasties [7]. One-stage exchange arthroplasty is
advocated by some surgeons with comparable outcomes
to two-stages surgeries. Extensive and radical soft tissue
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debridement and removal of the biofilm covered pros-
thesis are the main goals of one-stage revision arthroplasty
[8]. One-stage procedure has not been commonly used in
PJI because of uncertainty of total bacterial eradication,
which could be the cause of surgeon concern about recur-
rent infection. In most cases successful eradication of bac-
teria is considerably enhanced by correct identification of
the pathogen using tissue and joint fluid culture. Recent
studies revealed that 2–36 % of microorganisms in the in-
fected joint replacements were not identified [7, 9–12].
In the present study we investigated bacterial species
in supposedly healed PJI patients during second-stage
exchange arthroplasties. This study was designed to de-
tect and/or isolate bacteria presented on the surfaces of
the prefabricated antibiotic-loaded spacers during the sec-
ond stage revision surgery. In our previous study we iden-
tified the bacteria on removed loosened prosthesis with
the use of sonication and PCR (polymerase chain reaction)
procedures in patients without elevated inflammatory
markers. Our clinical interest to perform this study was
to find the answer to following questions: if the supposedly
healed PJI should be considered as aseptic without the fear
for reimplantation and if failures could be predictable in
some cases?
The aims of the present study were: (1) to show that
sonication followed by PCR can improve bacterial identi-
fication on the surfaces of spacers used as a temporary
implant eluting antibiotic in the site of periprosthetic in-
fection, (2) to prove that the normalization of laboratory
markers does not exclude silent persistent infection and
the presence of bacteria on spacer surfaces, and (3) to
determine if laboratory markers of infection and culture
results were related to failure at 2-years follow-up.
Methods
Patients
Thirteen patients (7 women and 6 men) aged 50–84
years (mean age 69.2), before second-stage surgery of PJI,
were qualified to this study. We recruited 13 patients
(4 with hip and 9 with knee diagnosed joint infection)
attending the Department of Orthopaedic and Traumatol-
ogy, Medical University of Silesia, School of Medicine in
Katowice, Poland. The average period between the first
and second stage of revision arthroplasty was calculated at
153.1 days (approximately 5 months). Minimum follow-
up on these 13 patients was 2 years (mean, 32 months;
range, 25–36 months). No patients were lost to follow-up.
Failure was considered as clinical failure in case of persist-
ent or recurrent local signs of infection confirmed by
positive culture results requiring long-term antimicro-
bial therapy and/or reoperation. Clinical examination,
radiological assessment and determination of inflamma-
tory markers were conducted between stages of revision
arthroplasties.
This study was approved by the Ethics Committee of
the Medical University of Silesia in Katowice, Poland
(No. of Decisions: KNW/0022/KB1/160/III/11/12 and
KNW/0022/KB1/160/V/11/12). The patients were in-
formed about the aim and methods of this study and
gave written informed consent. Also, consent for publi-
cation of raw data was obtained from study participants.
Inclusion criteria were: patient was operated in our
Department awaiting second-stage revision arthroplasty
of hip or knee, primary qualified as PJI, or highly sus-
pected as PJI, based on the established criteria [2, 3].
Exclusion criteria were: antibiotics administration 2 weeks
before revision arthroplasty, other established infection sites
in the organism, rheumatoid arthritis, immunosuppression
and/or chemotherapy, and lack of patient consent for
participation in the study.
Surgical management
Patients were qualified to the two-stage revision arthro-
plasties. The first stage included removal of the compo-
nents of prosthesis and/or cement, debridement of necrotic
and granulation tissue, and the implantation of a prefabri-
cated antibiotic-loaded cement spacer with gentamicin
(Spacer-K and Spacer G manufactured by Tecres S.P.A.,
Verona, Italy). The standard prophylactic antibiotic therapy
was cefamandole. In case of allergy to beta-lactam antibi-
otics, vancomycin or clindamycin was administered. In case
of positive intraoperative specimen after the first stage,
antibiotic therapy was adjusted according to the micro-
biological findings. The empirical or targeted antibiotic
therapy was administered for 6 weeks. After normalization
of infection markers and lack of periprosthetic infection
clinical symptoms, the next step of exchange arthroplasty
was undertaken. In the second stage of revision arthro-
plasty, the temporary spacer was removed and revision
hip or knee system or arthrodesis (patient 13) was applied.
The arthrodesis of the knee joint was performed due to a
general medical condition of the patient that precluded
major surgery and high risk of reinfection.
Microbiological and Molecular methods
Intraoperative tissue samples taken during the first stage
of exchange arthroplasty (removal of the implants, de-
bridement, and spacer implantation) were cultured. Be-
fore cutting the pseudocapsule during the second stage
of the operation (removal of spacers and implantation of
a new prosthesis or, eventually, arthrodesis), the joint was
aspirated. During the surgery, at least 3–6 tissue specimens
for microbiological culture were also taken. Specimens
were cultured on Schaedler medium, Columbia agar with
5 % defibrinated sheep blood and Mannitol-salt, MacConkey,
Sabouraud agars (37 °C for at least 48 h). The cultures
were prolonged up to 14 days for slow-growing and fas-
tidious microorganisms. The identification of isolated
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Treatment Culture result -
1st stage
Culture results - 2nd stage Molecular identification Bacteria




25–36 months)Intraop. specimen Preop. samples
(joint fluid)
Intraop. specimen Sonicate
1 H <5 263 Restoration Stryker negative negative negative negative Geobacillus stearothermofilus,
G. vulcani
healed
2 H <5 150 Centrament
Aesculap
negative negative negative negative Lactobacillus jensenii, L.
acidophilus, L. fornicalis
death
3 K <5 146 Scorpio TS Stryker negative negative negative negative Pseudomonas aeruginosa,
P. resinovorans
healed






5 H 6,4 145 Restoration Stryker negative negative negative negative Klebsiella pneumoniae healed
6 K <5 170 Scorpio TS Stryker negative negative negative negative Klebsiella pneumoniae healed
7 K 6 184 Scorpio TS Stryker Micrococcus sp. negative negative negative S. lugdunensis, S. hominis healed
8 K <5 88 Scorpio TS Stryker Streptococcus
viridans
negative S. epidermidis negative Corynebacterium ureicelerivorans,
C. mucifaciens
healed





10 K <5 150 Scorpio TS Stryker Enterococcus
faecalis
negative negative negative Tuberibacillus calidus, Bacillus algicola healed








12 H <5 135 Restoration Stryker Enterococcus
faecium
negative negative negative Brevibacterium ravenspurgense,
B. paucivorans
healed





















strains was based on morphology of the colonies, micro-
scopic examination, and biochemical tests (microbiological
analyzer Vitek 2 compact, bioMérieux, Marcy L’Etoile,
France). Removed prefabricated spacers were subjected
to sonication and molecular detection as previously de-
scribed [13].
Histopathological tests
Soft tissue surrounding the spacer and periprosthetic
interface membrane were taken for histopathological test-




CRP (C-reactive protein) was significantly elevated in 1
of 13 cases. In this case (patient nr 11) the failure after
2-years observation was noted. In remaining two cases
CRP level was minimally elevated without failures in
follow up. In the group with no elevated CRP level (10
patients) we noted 4 culture-positive cases (patients 4,
8, 9, 13) and only in case nr 13 it was related to failure.
Microbiological results
Intraoperative specimens after first stage
The result of tissue cultures in the first stage of surgery
were positive in 7 cases with the growth of Micrococcus
sp., Streptococcus viridans, Escherichia coli, Enterococcus
faecalis, Enterococcus faecium, Enterobacter cloacae, Aci-
netobacter baumannii, and Staphylococcus aureus. Six
out of 13 studied cases did not reveal the growth of mi-
croorganisms and no failures in 2 years follow-up were
noted.
Joint fluid culture
The negative joint fluid culture results before second-
stage revision were obtained in all 13 cases.
Intraoperative specimens during 2nd stage
In 2 cases (15 %) a positive culture revealed the growth of
CNS (Coagulase-Negative Staphylococci)—Staphylococcus
epidermidis. In case nr 8 this culture was not concordant
with sonicate fluid negative culture and no failure was ob-
served. In contrast to this case, in the case of patient nr 13
the positive culture of tissue sample was concordant with
the positive culture of sonication fluid and a failure was
Fig. 1 X-rays (AP and lateral view) of loosened implants of unicompartmental knee arthroplasty
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noted. The culture results of intraoperative specimens
were negative in remaining 11 cases.
Sonicate culture
In three cases cultures of sonicate liquid revealed the
presence: in one case S. epidermidis (patient nr 13) and
in two cases Ralstonia pickettii (patients nr 4 and 9).
Failure was noted only in case nr 13 with the S. epidermidis
growth. In remaining two cases of R. pickettii growth
no failure was observed. We found 77 % compatibility
(10 cases) between culture results of synovial fluid ob-
tained through the joint aspiration and sonicate fluid
obtained from components of prosthesis, and 69 %
compatibility (9 cases) when cultures of intraoperative
specimens and sonicate fluid results were analyzed. The
sonicate cultures were negative in 10 cases (Table 1).
Molecular detection
The presence of bacterial DNA (deoxyribonucleic acid)
was confirmed with molecular testing in 92 % of patients
with negative synovial fluid cultures. In most samples,
positive PCR results revealed presence of 2 or more dif-
ferent opportunistic bacteria (eg, S. epidermidis, Klebsiella
pneumoniae, Acinetobacter spp., Pseudomonas spp.,
Lactobacillus spp.) and most of them belongs to human
or environmental microflora with low virulence. All re-
sults are presented in Table 1.
Histopathological test
The results of histopathological tests revealed the pres-
ence of infection features (type II) in all cases. Type II is
defined as the presence of activated fibroblasts, prolifer-
ation of small blood vessels, edema, and inflammatory
infiltration of neutrophilic granulocytes in the peripros-
thetic membrane.
Follow-up
In 10 patients no failures were noted: lack of any clinical
features of infection, radiological findings of implants
loosening, increasing laboratory markers, and prolonged
antibiotic therapy. The clinical examination revealed good
outcomes. Failure at final follow-up was recorded in 2
(16.6 %) patients.
In patient nr 11 (Figs. 1, 2 and 3), the clinical data re-
vealed the periodic effusion without persistent pain, the
presence of MSSE (Methicilin Sensitive Staphylococcus
Fig. 2 X-rays (AP and lateral view) after 1st stage of two-stage revision arthroplasty (Spacer implantation)
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epidermidis) in 1/3 arthrocentesis performed in the early
postoperative period. A minimal radiolucency was noticed
under the tibial component, however no other radiological
feature of implants loosening was observed. This case was
not assessed as implant loosening (Fig. 3). However, in
2 years observation infection of S. epidermidis occurred.
Targeted antimicrobial therapy was administered. For
these reasons this case was assessed as a failure. The
second recognized failure (patient nr 13; Figs. 4 and 5)
was also due to infection with S. epidermidis. The deci-
sion about second-stage revision surgery was based on
the medical history of the patient: knee joint infection
many years ago, clinical signs of infection after primary
knee joint arthroplasty and the growth of S. aureus
from intraoperative tissue samples taken during the first-
stage revision surgery. This patient finally underwent arth-
rodesis of the knee joint due to general medical condition
and the high risk of reinfection. Prolonged wound healing,
the positive culture results from intraoperative specimens
and sonicate fluid (S. epidermidis) were the reason for
long-term antibiotic therapy in this case. We qualified this
case as a failure with the recognition of infection with S.
epidermidis.
One of the 13 patients was lost to follow-up due to
death, which did not occur perioperatively or within
90 days postoperatively, and arguably was not related to
the arthroplasty or infection (Table 1).
Discussion
We compared the intraoperative specimens, joint fluid,
and sonicate cultures with sequencing results. We found
that the diagnosis of “treated” PJI does not exclude the
presence of bacteria or bacterial DNA on the surface of
prefabricated spacers. Our literature search revealed few
studies identifying microorganisms on the surface of re-
moved antibiotic-loaded cement spacers using both son-
ication and 16S rRNA (ribosomal ribonucleic acid) gene
sequencing.
Two-stage exchange arthroplasty is a surgical strategy
for PJI treatment. It is considered as a standard proced-
ure for surgical treatment of late PJI, with treatment suc-
cess estimated at 73–89 % [7, 15]. The limited sensitivity
and specificity of standard bacterial culture techniques
may limit their ability to detect the adherent bacteria re-
sponsible for PJI [16, 17]. In the present study we cul-
tured the sonication fluid of removed spacers to confirm
the eradication of infection. This process considerably
enhances culture sensitivity and represents a cheap,
easy, accurate, and sensitive diagnostic modality compared
to periprosthetic tissue cultures. The technique is
Fig. 3 X-rays (AP and lateral view) of knee joint after second stage of revision arthroplasty (revision implants)
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simple and can be performed in most microbiology
laboratories [4, 17].
Recent studies reported 14.5 to 29 % positive sonicate
cultures of the removed spacers and noted that an infec-
tion of the cement spacer is associated with poor clinical
outcome [16, 18, 19]. The incidence of reinfection after
two-stage exchange arthroplasty has been estimated at
10–31 % [7, 16, 20]. Our study revealed the presence of
microorganisms on the surface of prefabricated spacers
in 2 cases in intraoperative specimens (15 %) and in 3
cases after sonication (23 %). The samples after sonication
in 1 case revealed S. epidermidis—a proven etiological
agent of infection related with biomaterials, and in the
2 other cases—R. pickettii. This Gram-negative, non-
fermenting bacteria, able to live in aquatic environment,
in low-nutrient conditions, and in hospital water supplies,
is more often indicated as the cause of osteomyelitis, men-
ingitis, and sepsis, especially in patients with risk factors.
Ryan and Adley described the bacteria from the Ralstonia
genera as emerging global opportunistic pathogens and
considered them to be as important as severe infec-
tions causative agents, such as Acinetobacter baumannii,
Pseudomonas aeruginosa, Burkholderia cepacia, and Ste-
notrophomonas maltophilia [20]. These bacilli were found
in intravascular catheters and other biological materials
[21]. The positive culture of R. pickettii should be inter-
preted in the aspect of the clinical findings and level of
inflammatory mediators. On the other hand, sonication
findings should be considered in the aspect of false posi-
tive results due to prostheses contamination at the operat-
ing room. Contamination is possible in the region of the
surgical site, during the collection and handling of the
samples, particularly if some fluids are added to the
sample and, rarely, during specimen processing in the
laboratory. Further studies concerning Ralstonia patho-
genicity are required.
The sonication procedure and PCR followed by se-
quencing were positive in 92 % of studied cases. PCR of
sonication fluid from removed spacers revealed the var-
iety of species in our study. Additional pathogens were
detected in other studies [22, 23]. For the microbiologic
diagnosis of prosthetic joint infection, PCR of sonicated
samples is more sensitive than tissue culture [24]. How-
ever, identification of bacterial DNA in PCR assay does
not confirm the presence of live bacteria. The identifica-
tion of etiological agents but also contaminating factors
is possible due to the high specificity of PCR techniques.
The main limitations of PCR relate to inherent problems
with contamination and sensitivity. Contamination arises
from bacterial DNA present in PCR reagents or inad-
vertently introduced during the collection and handling
of the sample. This is because sterile fluid may nonethe-
less contain microbial DNA. Contaminants detected
with the PCR (false-positive results) belong to the same
Fig. 4 X-rays (AP and lateral view) after 1st stage of surgery treatment with implantation of knee Spacer
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type of pathogens as the microorganisms causing low-
grade PJI, making the distinction of true-positive and
false-positive PCR results difficult [25]. In this study we
identified DNA of various bacterial species. Some of them
(eg, Klebsiella pneumoniae and Pseudomonas aeruginosa)
cause serious, life-threatening diseases, and others occur
in the human environment or food (eg, Lactobacillus spp.
Brevibacterium spp., and Corynebacterium spp.). Many of
the species are described as etiological agents of infection,
especially in patients with immunodeficiency [26, 27].
Our study estimated the average time between surgeries
to approximately 5 months. When analyzing other studies,
we noticed that the mean time between stages was com-
parable [6]. Based on several studies, we can conclude
that spacers should be left at the PJI site no longer than
6 months, but even 3 months could be enough for eradi-
cation of bacteria [28, 29]. The new IDSA (Infectious
Diseases Society of America) Guideline of PJI recommends
the period 6–14 weeks from resection arthroplasty to
reimplantation (4–6 weeks of antimicrobial therapy
and 2–8 weeks of antibiotic-free period). This delayed
reimplantation has been noted to be highly successful
[30]. This period of local antibiotic elution to the peri-
prosthetic infection site is considered as sufficient, and
the colonization of spacer surface with new microor-
ganisms can be prevented.
In our study histopathology of periprosthetic tissues
revealed the infectious type (type II) in all cases, point-
ing to the PJI. The periprosthetic membrane is an ideal
material for characterizing the type of inflammation by
histopathology and provides valuable evidence for the
underlying cause of failure [14].
We described treatment failure in 2 out of 13 patients
at 2.5-year follow-up. In 1 of them (patient 13), intraop-
erative and sonicate cultures were positive. Some studies
reported that the recurrence of infection may be more
frequent if caused by resistant bacteria such as methicillin-
resistant S. aureus (MRSA) and methicillin-resistant S.
epidermidis (MRSE) or in cases requiring multiple prior
open procedures [7, 31]. Nelson found 9 (50 %) patients
with reinfection out of 18 with positive sonicate cultures
[32]. Followed by recommendation of some authors
Fig. 5 X-rays (AP and lateral view) after removal of Spacer and arthrodesis of left knee joint
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removal of prosthesis or arthrodesis can be performed
in cases of serious comorbidity or unacceptable to the
patient repeated surgery or which seem deemed unsafe
[33]. In most cases (patients 1–12) patients underwent
two-stage exchanging arthroplasties with implantation
of the revision implants.
We had 1 death out of 13 patients. Another study re-
ported no patient deaths within 3 months after the oper-
ation and 16 % overall mortality rate [34].
Our previous as well as the present survey confirmed
the presence of bacterial DNA on both, the removed
loosed implants due to aseptic loosening and prefabri-
cated cement spacers used in two-stage revision arthro-
plasties [13].
In conclusion, this study confirmed that sonication
followed by PCR and sequencing improves bacterial de-
tection. The high rate of identified bacterial DNA in
presumed healed PJI is not considered in our study as a
cause of failures. The prolonged elevated CRP level in
one case, and previous infection of operated joint in the
second case were the reasons for failures. Thus, the treat-
ment strategy should be considered in the light of history
of the disease, comorbidities, clinical and laboratory re-
sults. Prolonged period between two stages of revision
arthroplasty could be the reason for colonization of spacer
surfaces with new microorganisms, especially dangerous
for patients with immunodeficiency. Taking into consider-
ation our results and observations of other authors, the
shortening of time interval between stages to 6–14 weeks
is beneficial [28–30].
Study limitations
The main limitations of our study are the small sample
size and the short period of observation. Larger studies
are needed to confirm these results before we could rec-
ommend them for wider use. Nevertheless, the results
are very promising.
Conclusion
Firstly, the lack of clinical signs of infection, negative
culture results of pre- and intraoperative samples do not
exclude existence of bacteria on the surfaces of pre-
formed antibiotic-loaded spacers used in two-stage ex-
change arthroplasties. Secondly, the positive results of
sonication and molecular tests should be interpreted as
real pathogenicity factors in the light of the clinical, micro-
biological and histopathological data, especially for patients
with immunodeficiency. Finally, more attention should be
paid to reimplantation of spacers in patients without clin-
ical symptoms of infection with prolonged elevated level of
CRP and in cases of prior infectious process of operated
joint. Above conclusions state the clinical significance of
our results and should be useful for clinicians.
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